Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

2,509.9 1,493.2

Accumulated other comprehensive income 55.7 87.8

(Accumulated deficit)/retained earnings (1,140.1) 353.0

_________ ________

Total shareholders' equity 1,227.0 1,942.3

_________ ________

Total liabilities and shareholders' equity 4,330.1 3,326.4

_________ ________

Unaudited US GAAP results for the three months and year to December 31,

2007

Consolidated Statements of Operations

3 months 3 months 12 months 12 months

to to to to

December December December December

31, 2007 31, 2006 31, 2007 31, 2006

$M $M $M $M

________ ________ ________ ________

Revenues:

Product sales 661.3 427.6 2,170.2 1,535.8

Royalties 61.8 61.1 247.2 242.9

Other revenues 1.4 8.3 18.9 17.8

_______ _______ ______ _______

Tota
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research Report ... "2014 Deep Research Report on Global and China ... Photo - http://photos.prnewswire.com/prnh/20140918/147058 ... and China Acetic Acid Industry" is a professional ... and Global Acetic Acid Market. The ...
(Date:9/18/2014)... Texas Governor Rick Perry, Texas ... Health Science Center CEO Brett Giroir, M.D., and ... Human Services (HHS), State of Texas and biopharmaceutical ... vaccine manufacturing facility in Bryan, Texas, which when ... Texas A&M Biocorridor – a rapidly evolving hub ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global Human Albumin Industry Report 2014" report to ... Industry Report 2014 is a professional and in-depth study ... industry. The report provides a basic overview ... chain structure. The human albumin market analysis is provided ...
(Date:9/18/2014)... Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... in the Biotech Industry conference on Friday, September 26, ... Hotel & Conference Center in New York ... at www.meipharma.com . A replay will be available approximately ...
Breaking Biology Technology:Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... , , , ... NBIX ) announced today that the Company will report its second ... July 29, 2009. Neurocrine will then host a live conference ... update Thursday morning, July 30, 2009 at 8:30 a.m. Eastern Daylight Time ...
... , , , ... Group , , NEW ... non-invasive molecular oncology diagnostics to aid in early cancer detection ... named Chief Operating Officer. As COO, Zdechlik will be ...
... ... the keynote address , ... Parsipany, NJ (PRWEB) July 22, 2009 -- Vistaar Technologies, Inc. Vistaar ... announced the company will partner with the Professional Pricing Society (PPS), the world,s only ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results 2Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 3
(Date:9/19/2014)... sense of fairness did not evolve for the sake ... the benefits of continued cooperation, so say Frans de ... review article about inequity aversion (IA), which is defined ... is published in Science . , Their ... IA-related studies to address their hypothesis that it is ...
(Date:9/18/2014)... University researchers have developed a unique method to use ... in rural areas. , The first microbe-powered, self-sustaining ... quick way to clean up waste from large farming ... , Professor Haluk Beyenal and graduate student Timothy ... discuss the system in the online edition of ...
(Date:9/18/2014)... New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), ... in humans similar to that caused by Ebolavirus, has ... discovery has the potential to lead to novel targets ... The research, reported in a paper published today in ... scientists at the Texas Biomedical Research Institute and their ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Researchers develop unique waste cleanup for rural areas 2Research milestone in CCHF virus could help identify new treatments 2
... virus called cytomegalovirus (CMV), which most commonly affects people ... patients who have no immune-system problems, University of Washington ... longer hospital and intensive-care unit (ICU) stays independent of ... in JAMA , the Journal of the ...
... stem cells originate in a different part of the brain ... produce new brain cells to replace those lost to disease ... Evidence strongly shows that the true stem cells in ... ventricles in the brain and spinal cord, rather than cells ...
... In the life of a cell, the response to DNA damage ... commit suicide, or grow uncontrollably, a route leading to cancer. In ... Cell , scientists at NYU Langone Medical Center have identified a ... targets proteins for disposal. The finding points to a new pathway ...
Cached Biology News:CMV infections affect more than just patients with compromised immune systems, researchers find 2Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3A new cellular pathway linked to cancer is identified by NYU researchers 2
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Catch and Release® v2.0 Reversible Immunoprecipitation System...
... Peptide-Protein Conjugation, Quantities ... Complex Peptides/Peptidomimetics, Special amino ... Structures, Peptide labeling AMC, aldehyde, ... fitting your needs, Chromogenic/Flurogenic Substrates, ...
5-bromouridine 5'-triphosphate (BrUTP) *10 mM in TE buffer*...
Biology Products: